These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11134094

  • 21. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men.
    Doran PM, Riggs BL, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2001 Nov; 16(11):2118-25. PubMed ID: 11697809
    [Abstract] [Full Text] [Related]

  • 22. Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial.
    Greenspan SL, Resnick NM, Parker RA.
    J Clin Endocrinol Metab; 2005 May; 90(5):2762-7. PubMed ID: 15713726
    [Abstract] [Full Text] [Related]

  • 23. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
    Bonnick S, De Villiers T, Odio A, Palacios S, Chapurlat R, DaSilva C, Scott BB, Le Bailly De Tilleghem C, Leung AT, Gurner D.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4727-35. PubMed ID: 24064689
    [Abstract] [Full Text] [Related]

  • 24. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S, Caubel P, Garnero P, Felsenberg D.
    Maturitas; 2004 Jul 15; 48(3):197-207. PubMed ID: 15207885
    [Abstract] [Full Text] [Related]

  • 25. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
    Meier C, Liu PY, Ly LP, de Winter-Modzelewski J, Jimenez M, Handelsman DJ, Seibel MJ.
    J Clin Endocrinol Metab; 2004 Jun 15; 89(6):3033-41. PubMed ID: 15181095
    [Abstract] [Full Text] [Related]

  • 26. Effects of low-dose prednisone on bone metabolism.
    Ton FN, Gunawardene SC, Lee H, Neer RM.
    J Bone Miner Res; 2005 Mar 15; 20(3):464-70. PubMed ID: 15746991
    [Abstract] [Full Text] [Related]

  • 27. Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis.
    Palomba S, Orio F, Colao A, di Carlo C, Sena T, Lombardi G, Zullo F, Mastrantonio P.
    J Clin Endocrinol Metab; 2002 Apr 15; 87(4):1502-8. PubMed ID: 11932272
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Analysis of the contribution of dydrogesterone to bone turnover changes in postmenopausal women commencing hormone replacement therapy.
    Tobias JH, Clarke S, Mitchell K, Robins S, Amer H, Fraser WD.
    J Clin Endocrinol Metab; 2001 Mar 15; 86(3):1194-8. PubMed ID: 11238508
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.
    Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L.
    J Bone Miner Res; 2004 May 15; 19(5):737-44. PubMed ID: 15068496
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
    Longobardi S, Keay N, Ehrnborg C, Cittadini A, Rosén T, Dall R, Boroujerdi MA, Bassett EE, Healy ML, Pentecost C, Wallace JD, Powrie J, Jørgensen JO, Saccà L.
    J Clin Endocrinol Metab; 2000 Apr 15; 85(4):1505-12. PubMed ID: 10770189
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sublingual administration of micronized estradiol and progesterone, with and without micronized testosterone: effect on biochemical markers of bone metabolism and bone mineral density.
    Miller BE, De Souza MJ, Slade K, Luciano AA.
    Menopause; 2000 Apr 15; 7(5):318-26. PubMed ID: 10993031
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C, Riis BJ.
    J Clin Endocrinol Metab; 1990 Oct 15; 71(4):836-41. PubMed ID: 2205624
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.